Global New-Born Screening Market: Information by Product (Reagents and Assay Kits and Instruments), by Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays and Pulse Oximetry), by Test Type (Dry Blood Spot Test, Hearing Screening Test and Critical Congenital Heart Disease (CCHD) Test), by End User (Hospitals, Maternity and Specialty Clinics and Diagnostic Centers) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025Global Market - OverviewMarket HighlightsThe Global New-Born Screening Market is expected to register a CAGR of 13.33% during the forecast period with a market value of USD 1545.98 Million till 2025.
New-born screening involves the use of various devices for the screening procedure.Key Findings of the StudyThe Global New-Born Screening Market was valued at USD 745.52 million in 2018, is estimated to grow at USD 1545.98 Million by 2025 at a CAGR of 13.33% during the assessment period.Americas accounted for the largest share of the global market due to the presence of key market players and increasing the rising prevalence of congenital disorders in new-born, increasing neonatal population, and government support are driving the growth of the market in this region.On the basis of product, reagents and assay kits accounted for the largest market share of 9% in 2018, with a market value of USD 521.05 million.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6561 Segment AnalysisThe global new-born screening market is segmented into product, technology, test type, and end-userThe global new-born screening market by-products has been bifurcated into instruments and reagents and assay kits.
Based on the test type, it has been segregated into dry blood spot tests, critical congenital heart disease (CCHD) tests, urine tests, and hearing screening tests.
The global new-born screening market, by end-user, has been classified as hospitals, maternity and specialty clinics, diagnostic centers, and others.Regional AnalysisThe global new-born screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas are anticipated to hold a significant share in the global new-born screening market.
According to data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHD) affect approximately 1% or about 40,000 births per year in the US.
According to data published by the United Nation’s International Children’s Emergency Fund (UNICEF), the rate of neonatal mortality in India was 24% in 2017.